Literature DB >> 18242321

Good clinical practice and the conduct of clinical studies in pediatric oncology.

Susan Devine1, Ramzi N Dagher, Karen D Weiss, Victor M Santana.   

Abstract

This article discusses the principles that guide good clinical practice standards, with particular emphasis on how they to relate to pediatric oncology research and recent efforts at harmonization. The authors review the clinical trials process and the roles of the participants, highlighting the pivotal role of the clinical investigator and the research team, and briefly review the historical aspects of drug development regulations in the United States and the current regulatory paths for pediatric oncology drug development. Where relevant, historical events that underlie many of the regulations and their current applications are described, and practical examples are provided.

Entities:  

Mesh:

Year:  2008        PMID: 18242321      PMCID: PMC2276977          DOI: 10.1016/j.pcl.2007.10.008

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  16 in total

1.  Pediatric phase II cancer chemotherapy trials: a Pediatric Oncology Group study.

Authors:  S Weitman; S Ochoa; J Sullivan; J Shuster; N Winick; C Pratt; T Vietti; M Harris
Journal:  J Pediatr Hematol Oncol       Date:  1997 May-Jun       Impact factor: 1.289

2.  Optimal two-stage designs for phase II clinical trials.

Authors:  R Simon
Journal:  Control Clin Trials       Date:  1989-03

3.  The national impact of clinical cooperative group trials for pediatric cancer.

Authors:  S B Murphy
Journal:  Med Pediatr Oncol       Date:  1995-05

4.  Conduct of phase I trials in children with cancer.

Authors:  M Smith; M Bernstein; W A Bleyer; J D Borsi; P Ho; I J Lewis; A Pearson; F Pein; C Pratt; G Reaman; R Riccardi; N Seibel; R Trueworthy; R Ungerleider; G Vassal; T Vietti
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

5.  Response to paclitaxel, topotecan, and topotecan-cyclophosphamide in children with untreated disseminated neuroblastoma treated in an upfront phase II investigational window: a pediatric oncology group study.

Authors:  Cynthia S Kretschmar; Morris Kletzel; Kevin Murray; Paul Thorner; Vijay Joshi; Robert Marcus; E Ide Smith; Wendy B London; Robert Castleberry
Journal:  J Clin Oncol       Date:  2004-10-15       Impact factor: 44.544

6.  The measurement of performance in childhood cancer patients.

Authors:  S B Lansky; M A List; L L Lansky; C Ritter-Sterr; D R Miller
Journal:  Cancer       Date:  1987-10-01       Impact factor: 6.860

7.  Efficacy of topotecan and cyclophosphamide given in a phase II window trial in children with newly diagnosed metastatic rhabdomyosarcoma: a Children's Oncology Group study.

Authors:  David O Walterhouse; Elizabeth R Lyden; Philip P Breitfeld; Stephen J Qualman; Moody D Wharam; William H Meyer
Journal:  J Clin Oncol       Date:  2004-03-08       Impact factor: 44.544

Review 8.  Pediatric cancers in the new millennium: dramatic progress, new challenges.

Authors:  Lisa M McGregor; Monika L Metzger; Robert Sanders; Victor M Santana
Journal:  Oncology (Williston Park)       Date:  2007-06       Impact factor: 2.990

Review 9.  Phase I therapy trials in children with cancer.

Authors:  S Shah; S Weitman; A M Langevin; M Bernstein; W Furman; C Pratt
Journal:  J Pediatr Hematol Oncol       Date:  1998 Sep-Oct       Impact factor: 1.289

Review 10.  Regulatory approvals of pediatric oncology drugs: previous experience and new initiatives.

Authors:  Steven Hirschfeld; Peter T C Ho; Malcolm Smith; Richard Pazdur
Journal:  J Clin Oncol       Date:  2003-02-07       Impact factor: 44.544

View more
  5 in total

1.  American Society of Clinical Oncology policy statement update: the critical role of phase I trials in cancer research and treatment.

Authors:  Jeffrey S Weber; Laura A Levit; Peter C Adamson; Suanna Bruinooge; Howard A Burris; Michael A Carducci; Adam P Dicker; Mithat Gönen; Stephen M Keefe; Michael A Postow; Michael A Thompson; David M Waterhouse; Susan L Weiner; Lynn M Schuchter
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

Review 2.  Good Clinical Practice Guidance and Pragmatic Clinical Trials: Balancing the Best of Both Worlds.

Authors:  Robert J Mentz; Adrian F Hernandez; Lisa G Berdan; Tyrus Rorick; Emily C O'Brien; Jenny C Ibarra; Lesley H Curtis; Eric D Peterson
Journal:  Circulation       Date:  2016-03-01       Impact factor: 29.690

3.  Coordination and management of multisite complementary and alternative medicine (CAM) therapies: experience from a multisite reflexology intervention trial.

Authors:  Mohammad H Rahbar; Gwen Wyatt; Alla Sikorskii; David Victorson; Manouchehr Ardjomand-Hessabi
Journal:  Contemp Clin Trials       Date:  2011-06-02       Impact factor: 2.226

Review 4.  Clinical trials in children.

Authors:  Pathma D Joseph; Jonathan C Craig; Patrina H Y Caldwell
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

Review 5.  Legal and ethical issues in research.

Authors:  Camille Yip; Nian-Lin Reena Han; Ban Leong Sng
Journal:  Indian J Anaesth       Date:  2016-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.